Fuji Keizai Releases Reports on OTC Drug Market in Japan.Tokyo, Japan, June 20, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Japanese market researcher Fuji Keizai announced on June 20 that it has released a report on the over-the-counter (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). ) drug market in Japan. The report addresses 22 different efficacies in five indications including cold, urinary conditions and dental conditions. The market for OTC drugs, estimated at over 130 billion yen (US$1.1 bil), is shrinking. However, the report identifies three growing segments, namely, smoking-cessation aids, sedative sedative, any of a variety of drugs that relieve anxiety. Most sedatives act as mild depressants of the nervous system, lessening general nervous activity or reducing the irritability or activity of a specific organ. hypnotic drugs, and periodontal disease Periodontal Disease Definition Periodontal diseases are a group of diseases that affect the tissues that support and anchor the teeth. Left untreated, periodontal disease results in the destruction of the gums, alveolar bone (the part of the jaws where drugs. Entitled 'OTC Drug Data Book 2006: Vol.2', the report, available only in Japanese, sells for 94,500 yen (US$820). Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion